Rate My Professor Nigel Stallard

STALLard has made significant contributions to clinical trial methodology, including coordination of the InSPiRE project on innovative methods for small populations research under the European Commission's Seventh Framework Programme. He has published over 200 peer-reviewed articles in methodological and medical journals, with key works including 'Bayesian Approaches for Confirmatory Trials in Rare Diseases: Opportunities and Challenges' (2021), 'Efficient Adaptive Designs for Clinical Trials of Interventions With a Rare or Heterogeneous Disease' (2020), 'Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis' (2020, Lancet Neurology), and 'Statistical methods for clinical trials interrupted by the severe acute respiratory syndrome coronavirus 2 pandemic' (2024). His research has influenced trial designs in areas such as multiple sclerosis, COVID-19 respiratory failure, and neonatal seizures, advancing efficient and ethical approaches for challenging patient populations. Stallard has also contributed to editorial boards, workshops, and international collaborations, enhancing the impact of statistical methods in medical research.